Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Antibody Drug Conjugate (ADC)
1.2.3 Bispecific Antibody (BsAb)
1.3 Market by Application
1.3.1 Global Next Generation Antibody Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Other Non-Cancer Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Antibody Therapeutics Market Perspective (2018-2033)
2.2 Next Generation Antibody Therapeutics Growth Trends by Region
2.2.1 Global Next Generation Antibody Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Next Generation Antibody Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Next Generation Antibody Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Next Generation Antibody Therapeutics Market Dynamics
2.3.1 Next Generation Antibody Therapeutics Industry Trends
2.3.2 Next Generation Antibody Therapeutics Market Drivers
2.3.3 Next Generation Antibody Therapeutics Market Challenges
2.3.4 Next Generation Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Antibody Therapeutics Players by Revenue
3.1.1 Global Top Next Generation Antibody Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Next Generation Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Antibody Therapeutics Revenue
3.4 Global Next Generation Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Next Generation Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Antibody Therapeutics Revenue in 2022
3.5 Next Generation Antibody Therapeutics Key Players Head office and Area Served
3.6 Key Players Next Generation Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Next Generation Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Antibody Therapeutics Breakdown Data by Type
4.1 Global Next Generation Antibody Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2024-2033)
5 Next Generation Antibody Therapeutics Breakdown Data by Application
5.1 Global Next Generation Antibody Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Next Generation Antibody Therapeutics Market Size (2018-2033)
6.2 North America Next Generation Antibody Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Next Generation Antibody Therapeutics Market Size by Country (2018-2023)
6.4 North America Next Generation Antibody Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Antibody Therapeutics Market Size (2018-2033)
7.2 Europe Next Generation Antibody Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Next Generation Antibody Therapeutics Market Size by Country (2018-2023)
7.4 Europe Next Generation Antibody Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Antibody Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Next Generation Antibody Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Antibody Therapeutics Market Size (2018-2033)
9.2 Latin America Next Generation Antibody Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Next Generation Antibody Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Next Generation Antibody Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Antibody Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Next Generation Antibody Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Next Generation Antibody Therapeutics Introduction
11.1.4 Roche Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Next Generation Antibody Therapeutics Introduction
11.2.4 Amgen Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.2.5 Amgen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Next Generation Antibody Therapeutics Introduction
11.3.4 Pfizer Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Next Generation Antibody Therapeutics Introduction
11.4.4 Takeda Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.4.5 Takeda Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Detail
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo Next Generation Antibody Therapeutics Introduction
11.5.4 Daiichi Sankyo Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.5.5 Daiichi Sankyo Recent Development
11.6 Seagen
11.6.1 Seagen Company Detail
11.6.2 Seagen Business Overview
11.6.3 Seagen Next Generation Antibody Therapeutics Introduction
11.6.4 Seagen Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.6.5 Seagen Recent Development
11.7 Astellas
11.7.1 Astellas Company Detail
11.7.2 Astellas Business Overview
11.7.3 Astellas Next Generation Antibody Therapeutics Introduction
11.7.4 Astellas Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.7.5 Astellas Recent Development
11.8 Immunomedics
11.8.1 Immunomedics Company Detail
11.8.2 Immunomedics Business Overview
11.8.3 Immunomedics Next Generation Antibody Therapeutics Introduction
11.8.4 Immunomedics Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.8.5 Immunomedics Recent Development
11.9 GSK
11.9.1 GSK Company Detail
11.9.2 GSK Business Overview
11.9.3 GSK Next Generation Antibody Therapeutics Introduction
11.9.4 GSK Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.9.5 GSK Recent Development
11.10 Immunocore
11.10.1 Immunocore Company Detail
11.10.2 Immunocore Business Overview
11.10.3 Immunocore Next Generation Antibody Therapeutics Introduction
11.10.4 Immunocore Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.10.5 Immunocore Recent Development
11.11 ADC Therapeutics
11.11.1 ADC Therapeutics Company Detail
11.11.2 ADC Therapeutics Business Overview
11.11.3 ADC Therapeutics Next Generation Antibody Therapeutics Introduction
11.11.4 ADC Therapeutics Revenue in Next Generation Antibody Therapeutics Business (2018-2023)
11.11.5 ADC Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Antibody Drug Conjugate (ADC)
Table 3. Key Players of Bispecific Antibody (BsAb)
Table 4. Global Next Generation Antibody Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Next Generation Antibody Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Next Generation Antibody Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Next Generation Antibody Therapeutics Market Share by Region (2018-2023)
Table 8. Global Next Generation Antibody Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Next Generation Antibody Therapeutics Market Share by Region (2024-2033)
Table 10. Next Generation Antibody Therapeutics Market Trends
Table 11. Next Generation Antibody Therapeutics Market Drivers
Table 12. Next Generation Antibody Therapeutics Market Challenges
Table 13. Next Generation Antibody Therapeutics Market Restraints
Table 14. Global Next Generation Antibody Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Next Generation Antibody Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2022)
Table 17. Ranking of Global Top Next Generation Antibody Therapeutics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Next Generation Antibody Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Next Generation Antibody Therapeutics Product Solution and Service
Table 21. Date of Enter into Next Generation Antibody Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Next Generation Antibody Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2024-2033)
Table 27. Global Next Generation Antibody Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2024-2033)
Table 31. North America Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Next Generation Antibody Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Next Generation Antibody Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Next Generation Antibody Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Next Generation Antibody Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Next Generation Antibody Therapeutics Product
Table 49. Roche Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen Next Generation Antibody Therapeutics Product
Table 54. Amgen Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Next Generation Antibody Therapeutics Product
Table 59. Pfizer Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Takeda Company Detail
Table 62. Takeda Business Overview
Table 63. Takeda Next Generation Antibody Therapeutics Product
Table 64. Takeda Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Daiichi Sankyo Company Detail
Table 67. Daiichi Sankyo Business Overview
Table 68. Daiichi Sankyo Next Generation Antibody Therapeutics Product
Table 69. Daiichi Sankyo Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Daiichi Sankyo Recent Development
Table 71. Seagen Company Detail
Table 72. Seagen Business Overview
Table 73. Seagen Next Generation Antibody Therapeutics Product
Table 74. Seagen Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Seagen Recent Development
Table 76. Astellas Company Detail
Table 77. Astellas Business Overview
Table 78. Astellas Next Generation Antibody Therapeutics Product
Table 79. Astellas Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Astellas Recent Development
Table 81. Immunomedics Company Detail
Table 82. Immunomedics Business Overview
Table 83. Immunomedics Next Generation Antibody Therapeutics Product
Table 84. Immunomedics Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 85. Immunomedics Recent Development
Table 86. GSK Company Detail
Table 87. GSK Business Overview
Table 88. GSK Next Generation Antibody Therapeutics Product
Table 89. GSK Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 90. GSK Recent Development
Table 91. Immunocore Company Detail
Table 92. Immunocore Business Overview
Table 93. Immunocore Next Generation Antibody Therapeutics Product
Table 94. Immunocore Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 95. Immunocore Recent Development
Table 96. ADC Therapeutics Company Detail
Table 97. ADC Therapeutics Business Overview
Table 98. ADC Therapeutics Next Generation Antibody Therapeutics Product
Table 99. ADC Therapeutics Revenue in Next Generation Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 100. ADC Therapeutics Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Antibody Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Next Generation Antibody Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Antibody Drug Conjugate (ADC) Features
Figure 4. Bispecific Antibody (BsAb) Features
Figure 5. Global Next Generation Antibody Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Next Generation Antibody Therapeutics Market Share by Application: 2022 VS 2033
Figure 7. Cancer Case Studies
Figure 8. Haemophilia Case Studies
Figure 9. Other Non-Cancer Diseases Case Studies
Figure 10. Next Generation Antibody Therapeutics Report Years Considered
Figure 11. Global Next Generation Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Next Generation Antibody Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Next Generation Antibody Therapeutics Market Share by Region: 2022 VS 2033
Figure 14. Global Next Generation Antibody Therapeutics Market Share by Players in 2022
Figure 15. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Next Generation Antibody Therapeutics Revenue in 2022
Figure 17. North America Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Next Generation Antibody Therapeutics Market Share by Country (2018-2033)
Figure 19. United States Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Next Generation Antibody Therapeutics Market Share by Country (2018-2033)
Figure 23. Germany Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Next Generation Antibody Therapeutics Market Share by Region (2018-2033)
Figure 31. China Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Next Generation Antibody Therapeutics Market Share by Country (2018-2033)
Figure 39. Mexico Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Next Generation Antibody Therapeutics Market Share by Country (2018-2033)
Figure 43. Turkey Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Next Generation Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Roche Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 46. Amgen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 48. Takeda Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 49. Daiichi Sankyo Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 50. Seagen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 51. Astellas Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 52. Immunomedics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 53. GSK Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 54. Immunocore Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 55. ADC Therapeutics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed